Compare VCYT & DAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VCYT | DAVE |
|---|---|---|
| Founded | 2006 | 2017 |
| Country | United States | United States |
| Employees | N/A | 280 |
| Industry | Medical Specialities | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.1B |
| IPO Year | 2013 | N/A |
| Metric | VCYT | DAVE |
|---|---|---|
| Price | $51.41 | $286.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | $44.00 | ★ $312.75 |
| AVG Volume (30 Days) | ★ 1.2M | 573.5K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 164.52 | N/A |
| EPS | ★ 0.35 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.76 | $26.28 |
| Revenue Next Year | $12.35 | $17.38 |
| P/E Ratio | $145.49 | ★ $17.85 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.61 | $152.21 |
| 52 Week High | $52.45 | $318.66 |
| Indicator | VCYT | DAVE |
|---|---|---|
| Relative Strength Index (RSI) | 68.75 | 59.27 |
| Support Level | $40.27 | $231.19 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 2.41 | 22.52 |
| MACD | -0.11 | 2.85 |
| Stochastic Oscillator | 80.07 | 64.37 |
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit, short-term liquidity, fee-free banking, and financial management tools, and finding side gigs.